CHRNB2 — Cholinergic Receptor Nicotinic Beta 2 Subunit

CHRNB2 — Cholinergic Receptor Nicotinic Beta 2 Subunit

Introduction

Chrnb2 — Cholinergic Receptor Nicotinic Beta 2 Subunit is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

<div class="infobox infobogene"> [@smad]
| Field | Value | [@transcriptional]
|-------|-------| [@neuroinflammation]
| Gene Symbol | CHRNB2 | [@astrocyte]
| Full Name | Cholinergic Receptor Nicotinic Beta 2 Subunit |
| Chromosomal Location | 1q21.3 |
| NCBI Gene ID | 1145 |
| OMIM ID | 118507 |
| Ensembl ID | ENSG00000160716 |
| UniProt ID | P17787 |
| Associated Diseases | Epilepsy (Autosomal Dominant Nocturnal Frontal Lobe Epilepsy), Cognitive Impairment, Alzheimer's Disease, Parkinson's Disease, Nicotine Addiction |
</div>

Overview

CHRNB2 encodes the beta-2 subunit of the nicotinic [acetylcholine](/entities/acetylcholine) receptor (nAChR). This ligand-gated ion channel is a key component of cholinergic signaling in the brain and autonomic nervous system. The beta-2 subunit partners with alpha subunits to form functional receptors that mediate fast synaptic transmission at nicotinic synapses.

Function

Receptor Composition

CHRNB2-containing nAChRs can form:

• α4β2* nAChRs (most abundant in brain)
• α3β2* nAChRs (autonomic nervous system)
• α2β2* nAChRs (some brain regions)

The asterisk (*) indicates possible additional subunits.

Distribution

...

CHRNB2 — Cholinergic Receptor Nicotinic Beta 2 Subunit

Introduction

Chrnb2 — Cholinergic Receptor Nicotinic Beta 2 Subunit is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

<div class="infobox infobogene"> [@smad]
| Field | Value | [@transcriptional]
|-------|-------| [@neuroinflammation]
| Gene Symbol | CHRNB2 | [@astrocyte]
| Full Name | Cholinergic Receptor Nicotinic Beta 2 Subunit |
| Chromosomal Location | 1q21.3 |
| NCBI Gene ID | 1145 |
| OMIM ID | 118507 |
| Ensembl ID | ENSG00000160716 |
| UniProt ID | P17787 |
| Associated Diseases | Epilepsy (Autosomal Dominant Nocturnal Frontal Lobe Epilepsy), Cognitive Impairment, Alzheimer's Disease, Parkinson's Disease, Nicotine Addiction |
</div>

Overview

CHRNB2 encodes the beta-2 subunit of the nicotinic [acetylcholine](/entities/acetylcholine) receptor (nAChR). This ligand-gated ion channel is a key component of cholinergic signaling in the brain and autonomic nervous system. The beta-2 subunit partners with alpha subunits to form functional receptors that mediate fast synaptic transmission at nicotinic synapses.

Function

Receptor Composition

CHRNB2-containing nAChRs can form:

• α4β2* nAChRs (most abundant in brain)
• α3β2* nAChRs (autonomic nervous system)
• α2β2* nAChRs (some brain regions)

The asterisk (*) indicates possible additional subunits.

Distribution

| Brain Region | Receptor Type | Function |
|--------------|---------------|----------|
| [Hippocampus](/brain-regions/hippocampus) | α4β2 | Learning, memory |
| [Cortex](/brain-regions/cortex) | α4β2 | Attention, cognition |
| Thalamus | α4β2 | Sensory processing |
| Basal ganglia | α4β2 | Motor control, reward |
| VTA | α4β2 | Reward, addiction |

Physiological Roles

• Fast synaptic transmission
• Modulation of neurotransmitter release
• Regulation of neuronal excitability
• Cognitive processes (attention, learning, memory)

Disease Associations

Epilepsy

Autosomal Dominant Nocturnal Frontal Lobe Epilepsy (ADNFLE)

• CHRNB2 mutations cause familial epilepsy
• Mutations lead to gain-of-function
• Characterized by nocturnal seizures
• First identified in 2002 (Phillips et al.)

Alzheimer's Disease

• α4β2 nAChR expression decreases in AD
• [Amyloid-beta](/proteins/amyloid-beta) binding to receptors
• Loss of cholinergic signaling
• Therapeutic target ([donepezil](/entities/donepezil), rivastigmine)

Parkinson's Disease

• Altered nAChR expression in PD brain
• Nicotine may have neuroprotective effects
• LBD includes cholinergic deficits

Nicotine Addiction

• β2 subunit crucial for nicotine reward
• CHRNB2 variants affect nicotine dependence
• Knockout mice show reduced self-administration

Expression Pattern

Developmental Regulation

• Low expression at birth
• Increases during adolescence
• Highest expression in adult brain
• Region-specific patterns

Cell Type Expression

• Expressed in excitatory [neurons](/entities/neurons)
• Present in some inhibitory interneurons
• Not in glial cells

Therapeutic Targeting

Approved Drugs

| Drug | Target | Indication |
|------|--------|------------|
| Nicotine | α4β2, others | Smoking cessation |
| Varenicline | α4β2 partial agonist | Nicotine dependence |
| Cytisine | α4β2 partial agonist | Smoking cessation |

In Development

• α4β2-selective agonists for cognition
• Positive allosteric modulators
• Gene therapy approaches

Key Publications

PMID: 11834136(https://pubmed.ncbi.nlm.nih.gov/11834136/) - CHRNB2 mutations cause ADNFLE (2002)

PMID: 14675536(https://pubmed.ncbi.nlm.nih.gov/14675536/) - β2 subunit in nicotine addiction (2003)

PMID: 15671259(https://pubmed.ncbi.nlm.nih.gov/15671259/) - nAChRs in Alzheimer's disease (2005)

PMID: 21213306(https://pubmed.ncbi.nlm.nih.gov/21213306/) - Nicotinic receptors in PD (2011)

PMID: 25481418(https://pubmed.ncbi.nlm.nih.gov/25481418/) - α4β2 nAChR structure (2015)

Brain Atlas Resources

• [CHRNB2 Expression - Allen Human Brain Atlas](https://human.brain-map.org/microarray/search/show?search_term=CHRNB2)
• [CHRNB2 Expression - Allen Mouse Brain Atlas](https://mouse.brain-map.org/gene/show?gene_id=CHRNB2)
• [BrainSpan - CHRNB2 Developmental Expression](https://www.brainspan.org/static/download.html)

See Also

• [Nicotinic Acetylcholine Receptors](/entities/nicotinic-receptors)
• [Cholinergic Signaling](/mechanisms/cholinergic-signaling-neurodegeneration)
• [Epilepsy](/diseases/epilepsy)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Nicotine Addiction](/diseases/nicotine-addiction)

External Links

• [NCBI Gene: CHRNB2](https://www.ncbi.nlm.nih.gov/gene/1145)
• [UniProt: P17787](https://www.uniprot.org/uniprot/P17787)
• [OMIM: 118507](https://www.omim.org/entry/118507)
• [IUPHAR: α4β2 nAChR](https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=401)

Background

The study of Chrnb2 — Cholinergic Receptor Nicotinic Beta 2 Subunit has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

References

[Unknown, - TGF-beta signaling in neurodegeneration (n.d.)](https://pubmed.ncbi.nlm.nih.gov/27451067/)

[Unknown, - SMAD proteins in neural development (n.d.)](https://pubmed.ncbi.nlm.nih.gov/25009184/)

[Unknown, - Transcriptional regulation in AD (n.d.)](https://pubmed.ncbi.nlm.nih.gov/24668245/)

[Unknown, - Neuroinflammation and TGF-beta (n.d.)](https://pubmed.ncbi.nlm.nih.gov/25997342/)

[Unknown, - Astrocyte function in neurodegeneration (n.d.)](https://pubmed.ncbi.nlm.nih.gov/26245252/)